INBIFO Institut fir biologische Forschung GmbH - Kéin PREORITY
Report P 0500/3237 97/10/8 Page 70
lj.
kd sy 1200
& 4 : VIRGO-CA
FI 2 © : VIRGO-CC
a O : 1R4F
rae rere : without S9
z 1000 —— : with s9
Qo
=
 §
Ee
= 8
- 3 OO:
t
i
: 600 5
400 -
200 +

 

00 02 04 06 08 10
TPM DOSE (mg/plate}

8034/970926

Figure 4 Mutagenicity of TPM in Strain TA1535 ‘

Remarks: mean + SE, N = 12 plates
data see Tables 5, 10, 14, 24, 25, 32, and 33

SeZLbLZr90~e